Bioscience Clinic Dubai has unveiled its revolutionary Adipose Derived Stem Cell Technology (ADC) in the Middle East for the first time.
Located in Dubai Health Care City, Bioscience Clinic Middle East is
Sickle cell sufferers have been urged to make the switch to a life-changing drug that could drastically reduce complications. More than 40 per cent of sufferers being cared for at the Genetic Blood Disease Centre in Salmaniya Medical Complex (
Bahrain’s main specialist clinic treating patients with blood disorders will be expanded to cope with massive demand, the Gulf Daily News (GDN), our sister publication, has learnt. The Genetic Blood Disease Centre at Salmaniya M
Two more sickle cell disease patients have died from complications associated with the condition, prompting campaigners to accuse medics of failing to follow basic treatment protocols. Mahmood Mohammed Al Mahdi, 38, from A’ali, and Samee
Two women-only waiting areas for female sickle cell patients will be established in the Accident and Emergency (A&E) Department of Bahrain’s main hospital. The order was given yesterday by Health Minister Faeqa Al Saleh, just two day
Toyota Motor Corp is considering adding a fuel cell- powered car to its luxury brand Lexus by around 2020, the Nikkei reported on Thursday.
The company, which has already launched the fuel cell-powered Toyota M
Bahrain will play a key role in helping research a new drug to replace painkillers in the treatment of sickle cell anaemia, it has emerged. The year-long research programme is set to be launched on Wednesday (September 9) by Arabian Gulf Unive
Last month was the deadliest August for Bahrain’s sickle cell patients in three years, it has emerged. In total, nine sickle cell sufferers succumbed to complications related to the disease throughout July and August, according to figure
A Bahraini man has become the 14th person to die of complications from sickle cell anaemia this year.
Ali Isa Al Haddad died yesterday morning in India, where he was sent by the Health Ministry for treatment, said a report in the
The drug research field of cell therapy received a boost on Friday when British biotech company ReNeuron raised 68.4 million pounds ($106 million) to help fund its work into stroke, blindness and cancer.
ReNeuron, which has been t